Moffitt Notice of Blackbaud Data Incident. Learn More
Non-Hodgkin Lymphoma Outcomes
Exceptional patient outcomes and patient satisfaction are a key focus of cancer treatment at Moffitt Cancer Center. We understand that survival rates are an important factor in making your treatment decisions. We are proud our outcomes often exceed national averages and are committed to educating patients on our cancer treatment options and results.
The graphs below show the proportion of patients who survived one year and a minimum of five years after initial diagnosis. The survival rates are displayed by stage of the disease at initial diagnosis.
Early stage, which describes cancer that is early in its growth, may differ between cancer types. Intermediate stage cancers have grown more deeply into nearby tissue. The cancer may have spread to lymph nodes but not to other parts of the body. Advanced stage, also called metastatic cancer, means the cancer has spread to other parts of the body.
National rates calculated using the Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER *Stat Database: Incidence - SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2018 Sub (2000-2016) , National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2019, based on the November 2018 submission. Moffitt relative survival rates calculated using CNExT software version 1.18.1.